3Jalowy A , Schulz R, Dorge H , et al. Infarct size reduction by AT1 - receptor blockade through a signal cascade of AT2 - receptor activation,bradykininand prostaglandins in pigs. J Am Cull Cardiol, 1998, 32:1787～1796
5Ian M. C. Dixon,Haisong Ju,Davinder S. Jassal,David J. Peterson. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction[J] 1996,Molecular and Cellular Biochemistry(1):31～45
6Gary R,,Yusuf S.Overview of randomized trials of angiotensin-converting engyme in-hibitors on mortality and morbidity in patients with heart failure[].The Journal of The American Medical Association.1995
7Cohn JN.Results of Val-HeFT trial[].rd AHA Meeting.
8Mazayev VP,Fomina IG,Kazakov EN,et al.Valsartan in heart fail-ure patients previously untreated with an ACE inhibitor[].International Journal of Cardiology.1998
9Swedberg K,Pfeffer M,Granger C,et al.For the CHARM pro-gramme investigators.Candesartan in heart failure: assessment of re-duction in mortality and morbidity (CHARM): rational and design[].Journal of Cardiac Failure.1999
10Pitt B,Poole-Wilson P,Segal R,et al.Effects of losartan versus cap-topril on mortality in patients with symptomatic heart failure: ratio-nale, design and baseline characterlstics of patients in the losartan heart failure survival study-ELITE Ⅱ[].Journal of Cardiac Failure.1999
